Stock AnalizBritish American Tobacco p.l.c. BTI
Medicinal Chemicals and Botanical Products · IPO 1998 · data as of November 13, 2026
British American Tobacco p.l.c. (BTI) is a healthcare company listed in the US with a market value of about $133.7B. In the twelve months to June 30, 2026 it had revenue of $34.1B and net income of $8.4B, a net margin of 24.6%.
Its overall Stock Analiz score is 2.2 out of 5 (weak). The strongest part is value (3/5); the weakest is future growth (1/5).
Key numbers: a P/E of 15.9, a price to free cash flow of 15.1, 5-year revenue growth of -0% a year, a 5-year average ROIC of 2%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 26% below the current price.
Score: 2.2 / 5
Checks passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Profit margin improving
- ROE above 15%
- Positive free cash flow
- Interest covered more than 5 times
- Liabilities below 60% of assets
Checks not passed
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- 3-year free cash flow growth above 10% a year
- Strong R&D investment or growth above 20%
- 5-year EPS growth above 10% a year
- 5-year revenue growth above 8% a year
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $34.1B | $34.5B | $32.4B | $34.7B | $33.3B | $34.6B | $35.2B | $34.2B | $31.3B | $26.4B | $17.4B |
| Net income | $8.4B | $10.5B | $3.8B | -$18.3B | $8.0B | $9.2B | $8.7B | $7.5B | $7.7B | $50.7B | $5.7B |
| Free cash flow | $8.9B | $7.8B | $12.1B | $13.0B | $11.9B | $12.4B | $12.7B | $11.0B | $12.2B | $6.2B | $5.0B |
| EPS (diluted) | $3.84 | $4.84 | $1.78 | $-8.46 | $3.71 | $4.24 | $4.04 | $3.49 | $3.57 | $23.45 | $2.65 |
| Net margin | 24.6% | 30.3% | 11.9% | -52.7% | 24.1% | 26.5% | 24.8% | 22.0% | 24.6% | 191.6% | 32.9% |
| ROIC | — | 9.7% | 2.9% | -14.5% | 6.6% | 7.4% | 7.1% | 6.1% | 6.1% | 4.6% | 13.0% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
What is British American Tobacco p.l.c.’s P/E ratio?
About 15.9, based on the last twelve months of diluted earnings per share (forward P/E about 11.9).
Is British American Tobacco p.l.c. stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 26% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does British American Tobacco p.l.c. pay a dividend?
Yes. The dividend yield is about 5.40%, and it has paid dividends for 10 years in our data.
Is British American Tobacco p.l.c. a good stock to buy?
We do not give buy or sell advice. British American Tobacco p.l.c. scores 2.2 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.